Tuesday, March 17, 2026

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

Trump and Kim Min-seok Discuss North Korea: What’s Next for U.S.-Korea Relations?

Prime Minister Kim Min-seok meets President Trump to discuss North Korea relations, emphasizing his unique role in potential peace talks.

Tag: Cannes

No posts to display

Top News

- Our Sponsors Ad -

Follow us